Alora Pharmaceuticals Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 550

Employees

  • Latest Deal Type
  • Debt - PPP

  • Latest Deal Amount
  • $5.32M

Alora Pharmaceuticals General Information

Description

Producer of specialty pharmaceutical products in Alpharetta, Georgia. The company offers prenatal vitamins, adhd branded products, dermatologics, nutraceuticals, gastroenterology therapeutics, and endocrinology products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Corporate Office
  • 1880 McFarland Parkway
  • Alpharetta, GA 30005
  • United States
+1 (678)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 1880 McFarland Parkway
  • Alpharetta, GA 30005
  • United States
+1 (678)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alora Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Debt - PPP 09-Apr-2020 $5.32M Completed Generating Revenue
3. Debt - General 20-May-2016 Completed Generating Revenue
2. Debt Refinancing 17-Sep-2013 $89M $89M Completed Generating Revenue
1. Debt - General Completed Generating Revenue
To view Alora Pharmaceuticals’s complete valuation and funding history, request access »

Alora Pharmaceuticals Patents

Alora Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3230309-A1 Stable gabapentin powder Pending 31-Aug-2021
EP-4395758-A1 Stable gabapentin powder Pending 31-Aug-2021
EP-4395758-A4 Stable gabapentin powder Pending 31-Aug-2021
US-20250127739-A1 Stable gabapentin powder Pending 31-Aug-2021
WO-2023034269-A1 Stable gabapentin powder Inactive 31-Aug-2021 A61K31/195
To view Alora Pharmaceuticals’s complete patent history, request access »

Alora Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alora Pharmaceuticals Investments & Acquisitions (4)

Alora Pharmaceuticals’s most recent deal was a Early Stage VC with Talus Labs for . The deal was made on 26-Nov-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Talus Labs 26-Nov-2024 Early Stage VC Software Development Applications
Alora Pharmaceuticals (Dsuvia) 03-Apr-2023 Corporate Asset Purchase Buildings and Property
Osmotica Pharmaceuticals (Legacy Business) 30-Aug-2021 Merger/Acquisition Pharmaceuticals
Sovereign Pharmaceuticals 01-Jan-2019 Merger/Acquisition BPO/Outsource Services
To view Alora Pharmaceuticals’s complete investments and acquisitions history, request access »

Alora Pharmaceuticals FAQs

  • When was Alora Pharmaceuticals founded?

    Alora Pharmaceuticals was founded in 2007.

  • Where is Alora Pharmaceuticals headquartered?

    Alora Pharmaceuticals is headquartered in Alpharetta, GA.

  • What is the size of Alora Pharmaceuticals?

    Alora Pharmaceuticals has 550 total employees.

  • What industry is Alora Pharmaceuticals in?

    Alora Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Alora Pharmaceuticals a private or public company?

    Alora Pharmaceuticals is a Private company.

  • What is Alora Pharmaceuticals’s current revenue?

    The current revenue for Alora Pharmaceuticals is .

  • How much funding has Alora Pharmaceuticals raised over time?

    Alora Pharmaceuticals has raised $134M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process